South Korea-based International Vaccine Institute (IVI) has commenced a technology transfer of simplified Oral Cholera V...
At the mRNA Technology Transfer Program organized by the World Health Organization (WHO) and Medicines Patent Pool (MPP)...
The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced that a Phase 3 clinical trial to asses...
There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published in The...
A top-ranking public research university in Belgium has received funding from Norway-based Coalition for Epidemic Prepar...
SK bioscience, South Korea-based vaccine and biotech company, has broken ground on a major expansion of its vaccine manu...
Scientists in the US are set to test a new vaccine approach that could overcome some of the challenges associated with t...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Japan's NEC Corporation, AI and digital tech firm along with Transgene, which develops virus-based immunotherapies for c...
South Korea-based International Vaccine Institute (IVI) will open a Country and Project Office in Kenya dedicated to the...
Medidata, a subsidiary of Dassault Systèmes, a leading provider of clinical trial solutions for the life sciences...
South Korea-based International Vaccine Institute (IVI), and the Ministry of Health of Rwanda have announced that IVI wi...
Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...
SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...
US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...
